With the recent approval of tolterodine and oxybutynin XL, we believe that the list of agents previously considered first- and second-line medications for the overactive bladder needs to be revised.

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Drugs to treat overactive bladder don't work very well, according to a recent CR Best Buy Drugs analysis. Studies have found that only a small proportion of people get full relief of their ...

An overactive bladder may be temporary or become a chronic condition. How long the symptoms last may depend on factors like the underlying cause and treatment adherence. Some conditions may cause ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

This is called an Overactive Bladder ( OAB ... assess both the storage and voiding phases of the urinary bladder. What are the treatment options available ? The conservative strategies to ...

Gemtesa is approved for men with overactive bladder symptoms who are receiving pharmacologic treatment for benign prostatic hyperplasia.

If so, Medicare Part D will cover your prescription. Medications that relax your bladder can provide relief from an overactive bladder. You can get coverage for these prescriptions through ...